Biological insight in new drug combinations
Biological insight in new drug combinations
Managing osteonecrosis of the jaw
Celebrating a 10 year partnership: ecancer and the IEO
Precision medicine enabled histology agnostic development of immunotherapeutics
Triplet therapy for all comers in the CLL-BAG trial
Blood thinners a risk with cancer-associated venous thromboembolism
Risk and benefit of anti-coagulants for elderly patients with cancer-associated venous thromboembolism
Delayed exposure to common infections causes acute childhood leukaemia
Dacomitinib for EGFR positive lung cancer
Dose escalation results of ceritinib and nivolumab for ALK NSCLC
Tivantinib as second line therapy for high-MET HCC
No link between pregnancy and breast cancer relapse